ACE and kidney disorder: Compound homozygosity (i.e., ACE D/D + PAI-1 4G/4G) for ACE and PAI-1 polymorphisms that have been linked to increased cardiovascular disease and renal disease risk was associated with an increased incidence of macroangiopathic disease in diabetic patients.